324 related articles for article (PubMed ID: 28423603)
41. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis.
Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M
Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328
[TBL] [Abstract][Full Text] [Related]
42. Raman spectroscopy for grading of live osteosarcoma cells.
Chiang YH; Wu SH; Kuo YC; Chen HF; Chiou A; Lee OK
Stem Cell Res Ther; 2015 Apr; 6(1):81. PubMed ID: 25928011
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
44. STAT3 and its targeting inhibitors in osteosarcoma.
Liu Y; Liao S; Bennett S; Tang H; Song D; Wood D; Zhan X; Xu J
Cell Prolif; 2021 Feb; 54(2):e12974. PubMed ID: 33382511
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-11 regulates the fate of adipose-derived mesenchymal stem cells via STAT3 signalling pathways.
Yang W; Zhang S; Ou T; Jiang H; Jia D; Qi Z; Zou Y; Qian J; Sun A; Ge J
Cell Prolif; 2020 May; 53(5):e12771. PubMed ID: 32270546
[TBL] [Abstract][Full Text] [Related]
46. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
[TBL] [Abstract][Full Text] [Related]
47. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
48. ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β-catenin signalling pathways.
Huang H; Han Y; Chen Z; Pan X; Yuan P; Zhao X; Zhu H; Wang J; Sun X; Shi P
J Cell Mol Med; 2020 May; 24(10):5652-5664. PubMed ID: 32285603
[TBL] [Abstract][Full Text] [Related]
49. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
Wang X; Goldstein D; Crowe PJ; Yang JL
Anticancer Res; 2014 Nov; 34(11):6537-45. PubMed ID: 25368256
[TBL] [Abstract][Full Text] [Related]
50. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
52. Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma.
Chang H; Dong T; Ma X; Zhang T; Chen Z; Yang Z; Zhang Y
Biochem Biophys Res Commun; 2015 Aug; 464(1):45-50. PubMed ID: 26032498
[TBL] [Abstract][Full Text] [Related]
53. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
54. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
55. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
[TBL] [Abstract][Full Text] [Related]
56. PRG4 represses the genesis and metastasis of osteosarcoma by inhibiting PDL1 expression.
Zhang L; Ren H; Wu Y; Xue L; Bai Y; Wei D; Wu Q
Tissue Cell; 2024 Jun; 88():102409. PubMed ID: 38781792
[TBL] [Abstract][Full Text] [Related]
57. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
58. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
59. Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway.
Chu Y; Wang Y; Li K; Liu M; Zhang Y; Li Y; Hu X; Liu C; Zhou H; Zuo J; Peng W
Cell Signal; 2020 May; 69():109549. PubMed ID: 31987780
[TBL] [Abstract][Full Text] [Related]
60. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
